2.11
price down icon4.09%   -0.09
 
loading

Nkarta Inc Aktie (NKTX) Neueste Nachrichten

pulisher
Apr 24, 2025

A stock that deserves closer examination: Estrella Immunopharma Inc (ESLA) - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Technical analysis of Nkarta Inc (NKTX) stock chart patterns - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 2.18 - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Insider Sale Alert: Nkarta Inc [NKTX] – Is it Time to sell? - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

A Tale of Resilience: Nkarta Inc Amid Stock Market Turbulence - investchronicle.com

Apr 23, 2025
pulisher
Apr 21, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives Average Rating of “Buy” from Brokerages - Defense World

Apr 21, 2025
pulisher
Apr 18, 2025

JPMorgan Chase & Co. Raises Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 18, 2025
pulisher
Apr 16, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 16, 2025
pulisher
Apr 15, 2025

Nkarta (NKTX) Upgraded to Buy: Here's Why - NewsBreak: Local News & Alerts

Apr 15, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Boosts Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Natural Killer Cell Therapy Market Hits New High | Major Giants Nkarta Therapeutics, Kiadis Pharma - newstrail.com

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Buys 7,378 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Invests $57,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Nkarta’s (NKTX) Buy Rating Reiterated at Needham & Company LLC - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Nkarta (NASDAQ:NKTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

Apr 11, 2025
pulisher
Apr 11, 2025

Prudential Financial Inc. Sells 49,500 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

CAR NK Expert With 25-Year Track Record Strengthens Senti Bio's Scientific Leadership - Stock Titan

Apr 10, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Makes New Investment in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 05, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Cuts Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Nkarta to Participate in an April Investor Conference - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Leerink Partnrs Has Bullish Outlook for Nkarta Q1 Earnings - The AM Reporter

Apr 01, 2025
pulisher
Mar 31, 2025

Nkarta: Grinding Lower, Trying To Find Support (NASDAQ:NKTX) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Nkarta: Betting On The Turnaround (NASDAQ:NKTX) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

What is HC Wainwright’s Forecast for Nkarta Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

William Blair Estimates Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives $14.86 Average Price Target from Brokerages - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Stifel Nicolaus Has Lowered Expectations for Nkarta (NASDAQ:NKTX) Stock Price - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

What is HC Wainwright’s Forecast for Nkarta Q4 Earnings? - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Nkarta (NASDAQ:NKTX) - Defense World

Mar 29, 2025
pulisher
Mar 27, 2025

Nkarta’s Strategic Workforce Reduction and Clinical Progress Justify Buy Rating - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Analysts Adjust Price Targets For Nkarta And Bicara - Evrim Ağacı

Mar 27, 2025
pulisher
Mar 27, 2025

Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR), Perspective Therapeutics (CATX) and Nkarta (NKTX) - The Globe and Mail

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - BioPharma Dive

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel cuts Nkarta stock price target to $14, maintains buy rating - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta to lay off 34% of staff; Savara’s debt financing deal - Endpoints News

Mar 27, 2025
pulisher
Mar 27, 2025

H.C. Wainwright maintains Buy on Nkarta stock with $18 target By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

H.C. Wainwright maintains Buy on Nkarta stock with $18 target - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta lays off 3rd of staff to fund autoimmune CAR NK program - Fierce Biotech

Mar 27, 2025
pulisher
Mar 27, 2025

Newly pivoted to autoimmune, Nkarta trims staff by over third - FirstWord Pharma

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta’s Strategic Restructuring and NKX019 Progress Drive Buy Rating - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Announces Major Restructuring and Leadership Changes - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Inc To Reduce Workforce By 34%, Impacting 53 PositionsSEC Filing - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta's Strategic Reset: 34% Staff Cut Powers 5-Year Cash Runway with $380M War Chest - Stock Titan

Mar 26, 2025
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):